Identification and in vitro experimental investigation of missense SNPs implicate
错义 SNP 的鉴定和体外实验研究
基本信息
- 批准号:8366038
- 负责人:
- 金额:$ 28.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAlzheimer&aposs DiseaseAmino Acid SubstitutionAsthmaBindingCell Surface ReceptorsCommunitiesComplexComputer SimulationComputing MethodologiesCrohn&aposs diseaseDataDatabasesDevelopmentDifferential Scanning CalorimetryDiseaseDisease AssociationDown-RegulationDrug Delivery SystemsEnvironmental Risk FactorEvaluationGenetic VariationGenomeGenomicsGoalsHereditary DiseaseIn VitroIndividualInflammatory Bowel DiseasesInvestigationKnowledgeMethodsMicroarray AnalysisMolecularMutateNaturePlayPredispositionProcessPropertyProteinsResourcesRheumatoid ArthritisRiskRoleStructureSurface Plasmon ResonanceTechniquesThermodynamicsTimeUltracentrifugationVariantWorkdisorder riskgenetic variantgenome wide association studyhuman diseasein vivoinsightmacrophagemutantprotein functionresearch studytraitweb interface
项目摘要
DESCRIPTION (provided by applicant): Recent genome wide association studies have led to the reliable identification of multiple genomic loci where the presence of common SNPs is associated with altered risk of a number of common human diseases. These results offer the prospect of new insights into the nature of complex trait disease in general and specific understanding of the mechanisms underlying major common human diseases. Deriving insight into these underlying mechanisms is not trivial, and requires the development and application of a range of computational and experimental techniques. Molecular processes constitute a key part of the multiple level mechanisms by which SNPs influence disease risk, and a full understanding of their contributions is essential to effective investigation of higher level pathwa and subsystems impact, as well as evaluation of potential drug targets. This project focuses on the role of missense SNPs (those that result in an amino acid substitution in a protein) in disease mechanism. It is now clear that this class of SNP plays a substantial role in common disease mechanisms. We focus on loci associated with increased risk of Crohn's disease, where association studies have been particularly successful in identifying disease relevant loci. Previously developed computational methods are used to identify which of these SNPs are expected to have a large impact on the in vivo molecular function of the corresponding protein, and thus are most likely to be involved in disease mechanism. Currently, there are 39 proteins in 25 loci that have candidate high impact missense SNPs. Results of this analysis are combined with other available information to prioritize proteins for experimental study. In order to determine the precise effect on protein function, we will clone, express and purify a number of the high priority proteins and their SNP variants, and investigate in vitro properties, particularl structural stability and interaction with appropriate binding partners. We have demonstrated the power of this strategy for the case of macrophage stimulating factor (MSP), found to carry a candidate mechanism SNP for Crohn's disease, by establishing that binding to a cell surface receptor is impaired, implying down regulation of macrophage activity. Results of the experimental work together with computational modeling and annotation for all the Crohn's disease loci will made available through an online database and annotation facility, so that the results can be maximally exploited.
PUBLIC HEALTH RELEVANCE: New data are for the first time reliably establishing many associations between genetic variation among individuals and susceptibility to a number of common human diseases. These data open the way for investigation of the mechanisms underlying disease and hence the development of new therapies. This project will use computational and experimental methods to determine protein level mechanisms underlying disease loci for Crohn's, an inflammatory bowel disease.
描述(由申请人提供):最近的基因组广泛关联研究导致对多个基因组基因座的可靠鉴定,其中常见SNP的存在与许多常见人类疾病的风险改变有关。这些结果提供了对复杂性状疾病本质的新见解,并对主要常见人类疾病的机制进行了特定的理解。引导对这些基本机制的见解并不是微不足道的,需要开发和应用一系列计算和实验技术。分子过程构成了SNP会影响疾病风险的多级机制的关键部分,并且对其贡献的充分理解对于有效研究更高级别的PATHWA和子系统影响以及对潜在药物靶标的评估至关重要。该项目的重点是错义SNP(导致蛋白质中氨基酸取代的)在疾病机制中的作用。现在很明显,这类SNP在常见疾病机制中起着重要作用。我们专注于与克罗恩病风险增加相关的基因座,那里的关联研究在鉴定疾病相关的基因座方面特别成功。先前开发的计算方法用于确定这些SNP中的哪些有望对相应蛋白质的体内分子功能产生很大的影响,因此最有可能参与疾病机制。目前,25个基因座中有39种蛋白质具有高撞击错义SNP。该分析的结果与其他可用信息结合使用,以优先考虑蛋白质进行实验研究。为了确定对蛋白质功能的精确影响,我们将克隆,表达和纯化许多高优先蛋白及其SNP变体,并研究体外特性,特定的结构稳定性以及与适当结合伴侣的相互作用。我们已经证明了这种策略对于巨噬细胞刺激因子(MSP)的力量,发现通过确定与细胞表面受体的结合受损,这意味着降低了巨噬细胞活性的调节,从而携带了克罗恩病的候选机制SNP。实验性工作的结果以及所有克罗恩病基因座的计算建模和注释将通过在线数据库和注释设施提供,以便可以最大程度地利用结果。
公共卫生相关性:新数据首次可靠地建立了个体之间的遗传变异与对许多常见人类疾病的敏感性之间的许多关联。这些数据为研究疾病潜在机制的研究开辟了道路,从而开发了新疗法。该项目将使用计算和实验方法来确定克罗恩(Crohn's)(一种炎症性肠病)的蛋白质水平机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OSNAT HERZBERG其他文献
OSNAT HERZBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OSNAT HERZBERG', 18)}}的其他基金
Fumagillin Derivatives as Novel Antigiardiasis and Antiamebiasis Drugs
夫马洁林衍生物作为新型抗贾第鞭毛虫病和抗阿米巴病药物
- 批准号:
9089862 - 财政年份:2015
- 资助金额:
$ 28.88万 - 项目类别:
Fumagillin Derivatives as Novel Antigiardiasis and Antiamebiasis Drugs
夫马洁林衍生物作为新型抗贾第鞭毛虫病和抗阿米巴病药物
- 批准号:
8960227 - 财政年份:2015
- 资助金额:
$ 28.88万 - 项目类别:
Identification and in vitro experimental investigation of missense SNPs implicate
错义 SNP 的鉴定和体外实验研究
- 批准号:
8534208 - 财政年份:2012
- 资助金额:
$ 28.88万 - 项目类别:
Identification and in vitro experimental investigation of missense SNPs implicate
错义 SNP 的鉴定和体外实验研究
- 批准号:
8735958 - 财政年份:2012
- 资助金额:
$ 28.88万 - 项目类别:
Compound library screening using Giardia labmblia high throughput viability assay
使用贾第鞭毛虫高通量活力测定筛选化合物库
- 批准号:
8204416 - 财政年份:2010
- 资助金额:
$ 28.88万 - 项目类别:
Compound library screening using Giardia labmblia high throughput viability assay
使用贾第鞭毛虫高通量活力测定筛选化合物库
- 批准号:
8069710 - 财政年份:2010
- 资助金额:
$ 28.88万 - 项目类别:
Structure-Function studies of human hyaluronidases
人类透明质酸酶的结构-功能研究
- 批准号:
7778818 - 财政年份:2009
- 资助金额:
$ 28.88万 - 项目类别:
Mechanisms of action of SNPs associated with common disease
SNP与常见疾病相关的作用机制
- 批准号:
7713409 - 财政年份:2009
- 资助金额:
$ 28.88万 - 项目类别:
Structure-Function studies of human hyaluronidases
人类透明质酸酶的结构-功能研究
- 批准号:
8081238 - 财政年份:2009
- 资助金额:
$ 28.88万 - 项目类别:
Structure-Function studies of human hyaluronidases
人类透明质酸酶的结构-功能研究
- 批准号:
8074616 - 财政年份:2009
- 资助金额:
$ 28.88万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Towards the discovery of Nurr1-RXR modulators
致力于发现 Nurr1-RXR 调制器
- 批准号:
10750409 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别: